Letter to Editor on "A Randomized, Controlled, Blinded, Parallel-Group, Clinical Trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India"

Complement Ther Med. 2022 Apr 26:102838. doi: 10.1016/j.ctim.2022.102838. Online ahead of print.NO ABSTRACTPMID:35487344 | PMC:PMC9040503 | DOI:10.1016/j.ctim.2022.102838

Source: Complementary Therapies in Medicine - April 29, 2022 Category: Complementary Medicine Authors: Bharat Krushna Khuntia Aman Agarwal Gautam Sharma Source Type: research